Clinical Pharmacology of Novel Anti-Alzheimer Disease Modifying Medications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|13|15|1853-1863

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.15, 2013-08, pp. : 1853-1863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Approaches to Novel Anti-Alzheimer Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 25, 2004-10 ,pp. : 3167-3175

Bentham Science Publishers

Access to resources Recommend Favorite

Current Progresses of Novel Natural Products and Their Derivatives/ Analogs as Anti-Alzheimer Candidates: an Update

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-05 ,pp. : 870-887

Bentham Science Publishers

Access to resources Recommend Favorite

Possibility of a New Anti-Alzheimer's Disease Pharmaceutical Composition Combining Memantine and Vitamin D

By Annweiler Cédric   Beauchet Olivier  

Drugs & Aging, Vol. 29, Iss. 2, 2012-02 ,pp. : 81-91

Adis International

Access to resources Recommend Favorite

Metrifonate (Trichlorfon): a review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer’s disease

By Cummings J.L.   Ringman J.M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. : 463-471

Informa Healthcare

Access to resources Recommend Favorite

Dimeric and Hybrid Anti-Alzheimer Drug Candidates

By  

Current Medicinal Chemistry, Vol. 13, Iss. 4, 2006-02 ,pp. : 399-422

Bentham Science Publishers

Access to resources Recommend Favorite